BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33005298)

  • 1. Methylation changes at the
    Faias S; Duarte M; Pereira L; Chaves P; Cravo M; Dias Pereira A; Albuquerque C
    World J Gastrointest Oncol; 2020 Sep; 12(9):1056-1064. PubMed ID: 33005298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
    Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreas.
    Frampton AE; Stebbing J; Gall TM; Silver B; Jiao LR; Krell J
    Expert Rev Mol Diagn; 2015 Mar; 15(3):325-8. PubMed ID: 25656048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
    Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
    Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids.
    Paziewska A; Polkowski M; Goryca K; Karczmarski J; Wiechowska-Kozlowska A; Dabrowska M; Mikula M; Ostrowski J
    Dig Dis Sci; 2020 Aug; 65(8):2294-2301. PubMed ID: 31925676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
    Faias S; Duarte M; Albuquerque C; da Silva JP; Fonseca R; Roque R; Dias Pereira A; Chaves P; Cravo M
    Dig Dis Sci; 2018 Sep; 63(9):2351-2361. PubMed ID: 29796909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of GNAS and KRAS mutations in pancreatic cysts.
    Lee LS; Doyle LA; Houghton J; Sah S; Bellizzi AM; Szafranska-Schwarzbach AE; Conner JR; Kadiyala V; Suleiman SL; Banks PA; Andruss BF; Conwell DL
    JOP; 2014 Nov; 15(6):581-6. PubMed ID: 25435574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing adds value to the preoperative diagnosis of pancreatic cysts.
    Rosenbaum MW; Jones M; Dudley JC; Le LP; Iafrate AJ; Pitman MB
    Cancer Cytopathol; 2017 Jan; 125(1):41-47. PubMed ID: 27647802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreas.
    Ohtsuka T; Tomosugi T; Kimura R; Nakamura S; Miyasaka Y; Nakata K; Mori Y; Morita M; Torata N; Shindo K; Ohuchida K; Nakamura M
    Surg Today; 2019 Nov; 49(11):887-893. PubMed ID: 30879148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moray micro forceps biopsy improves the diagnosis of specific pancreatic cysts.
    Zhang ML; Arpin RN; Brugge WR; Forcione DG; Basar O; Pitman MB
    Cancer Cytopathol; 2018 Jun; 126(6):414-420. PubMed ID: 29660844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of pancreatic cystic neoplasm in routine clinical practice.
    Herranz Pérez R; de la Morena López F; Majano Rodríguez PL; Molina Jiménez F; Vega Piris L; Santander Vaquero C
    World J Gastrointest Endosc; 2021 Feb; 13(2):56-71. PubMed ID: 33623640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms.
    Yoshida K; Nagasaka T; Umeda Y; Tanaka T; Kimura K; Taniguchi F; Fuji T; Shigeyasu K; Mori Y; Yanai H; Yagi T; Goel A; Fujiwara T
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1557-69. PubMed ID: 27095449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms.
    Smith LA; Mckay CJ
    Minerva Med; 2014 Oct; 105(5):413-21. PubMed ID: 25000220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas.
    Bournet B; Vignolle-Vidoni A; Grand D; Roques C; Breibach F; Cros J; Muscari F; Carrère N; Selves J; Cordelier P; Buscail L
    Endosc Int Open; 2016 Dec; 4(12):E1228-E1235. PubMed ID: 27995180
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis.
    Tamura K; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Ideno N; Aso T; Miyazaki T; Ohuchida K; Takahata S; Ito T; Ushijima Y; Oda Y; Mizumoto K; Tanaka M
    Surgery; 2015 Feb; 157(2):277-84. PubMed ID: 25530484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
    Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
    Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma.
    Ideno N; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Aso T; Aishima S; Miyasaka Y; Ohuchida K; Ueda J; Takahata S; Oda Y; Mizumoto K; Tanaka M
    Pancreas; 2015 Mar; 44(2):311-20. PubMed ID: 25479586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.